Actively Recruiting

Age: 18Years +
All Genders
ID04463316

GROWing Up With Rare GENEtic Syndromes When Children With Complex Genetic Syndromes Reach Adult Age

Led by dr. Laura C. G. de Graaff-Herder · Updated on 2023-09-06

600

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying adults with rare and complex genetic syndromes that affect multiple body systems and often include intellectual disability. These patients typically receive specialized care from multiple specialists during childhood, but as medical advances have extended life expectancy, many are now living into adulthood. The study aims to understand the medical needs, comorbidities, medication use, and quality of life impacts for adults with these rare syndromes, addressing a gap in adult care and guidelines. This research involves a retrospective review of medical files, including medical history, laboratory results, additional tests, and records of physical and psychological complaints. There is no active treatment or intervention, as the study collects and analyzes existing data to gain insights about health issues and medication adaptations needed for these syndromes. Participants' medical records will be analyzed to evaluate the presence of physical health problems, laboratory values, physical and psychological complaints, and medication use over a one-year period. The study uses statistical software for analysis and aims to improve understanding of adult care needs for these rare genetic conditions. The study began in October 2018 and will continue through January 2030.

CONDITIONS

Brief Title

GROWing Up With Rare GENEtic Syndromes

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with rare syndromes or rare congenital diseases visiting the multidisciplinary outpatient clinic for patients with rare diseases at the department of endocrinology, internal medicine, Erasmus Medical Center.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 year

Participants undergo retrospective file studies including review of medical history, laboratory values, and assessments of physical and psychological complaints.

1 to 2 visits depending on data availability

Long-term Monitoring

Duration - Up to 1 year

Participants are observed over time to assess the presence of physical health problems, laboratory values, and medication use.

Periodic assessments during the year

Trial Site Locations

Total: 1 location

1

Erasmus Medical Center

Rotterdam, South Holland, Netherlands, 3015 GD

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Baseline-Controlled, Open-Label, Multicenter, Single-Arm S...

Rett Syndrome

Actively Recruiting

16 locations

An Open-label Phase 1/2/3 Study to Evaluate Safety and Effic...

Rett Syndrome

Actively Recruiting

6 locations

A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Phar...

Congenital Adrenal Hyperplasia

Actively Recruiting

33 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here